Predictive Biomarkers for Checkpoint Immunotherapy: Current Status and Challenges for Clinical Application

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-18-0214
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Predictive Biomarkers for Immunotherapy in Lung Cancer: Opportunities and Challenges

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Better Standards Sought for Predictive Immunotherapy Biomarkers

Cancer Discovery
Oncology
2018English

Immune Checkpoint Therapy and the Search for Predictive Biomarkers

Cancer Journal
Cancer ResearchOncology
2016English

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors

Advances in Therapy
MedicinePharmacology
2019English

Current Status of Xenotransplantation and Prospects for Clinical Application

Xenotransplantation
TransplantationImmunology
2009English

Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives

Cancers
Cancer ResearchOncology
2011English

Predictive Models for Nanotoxicology: Current Challenges and Future Opportunities

Regulatory Toxicology and Pharmacology
MedicineToxicology
2011English

Current Patent and Clinical Status of Stimulator of Interferon Genes (STING) Agonists for Cancer Immunotherapy

Pharmaceutical patent analyst
MedicineDrug DiscoveryPharmaceutical Science
2019English

Current Status and Future Technical Challenges for Tokamak Magnets

Fusion Science and Technology
Materials ScienceMechanical EngineeringCivilNuclearNuclear EnergyStructural EngineeringHigh Energy PhysicsEngineering
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy